It’s amazing
how much rides
on something
this small.
how much rides
on something
this small.
12mm CORNEA
TearLab is now Trukera Medical.
TearLab, founded in 2009, was built upon the recognition of the importance of corneal health to eye care practices. We introduced tear osmolarity testing to eye care with our flagship device, the TearLab Osmolarity System, which has been used to perform over 24 million tests worldwide. In 2022, we announced a corporate name change to Trukera Medical, for our further expansion in corneal health. What began with a focus on osmolarity testing is now a comprehensive corneal health company working to address additional unmet medical needs in eye care.
Our Vision
As Trukera Medical, it is our vision to be the world’s leading and most trusted corneal health company for providers and patients.
Our Portfolio
Trukera Medical offers a portfolio of products designed to meet the needs of eye care providers and their patients.
Are you overlooking a hidden danger? Toxic hyperosmolarity damages corneal cells and drives refractive instability. When hyperosmolarity occurs, salt content can be elevated to toxic levels. Left undiagnosed, it can adversely impact corneal health.1
Test for osmolarity. Manage what matters.
NEW!
The power of osmolarity testing in the palm of your hand
Portable
Specimen collection and analysis in one
Practical
Streamlined end-to-end testing process
Precise
Same trusted lab precision of 24 million tests
TearLab Osmolarity System
The TearLab Osmolarity System is the first-generation device that has provided objective point-of-care osmolarity testing to eye care providers for over a decade. Trukera Medical continues to support customers who currently possess these devices.
Comprehensive Support for Providers and Patients
Trukera Customer Portal provides everything you need at your fingertips
Delivering on our core value to remain customer-focused, the Trukera Customer Portal makes it convenient for you to order testing supplies, find helpful resources, access on-demand product training, and contact us for support. The portal includes a chat bot to help with brief technical and reimbursement support questions too.
Contact [email protected] for help accessing the portal
Helping you deliver quality patient education
Trukera Medical’s commitment to corneal health is brought to life by delivering valuable patient education.
Access the Trukera Customer Portal to find digital and printed resources to:
- Educate patients about osmolarity
- Explain the impact of hyperosmolarity on the eye
- Track osmolarity scores over time
Trukera Team
Trukera Medical remains under the stable management of a talented team of leaders
MANAGEMENT TEAM
Adam Szaronos
President and Chief Executive Officer
Adam Szaronos
President and Chief Executive Officer
Adam Szaronos joined the executive leadership team in June 2020 to oversee the company’s global expansion efforts. Adam brings 15 years of industry experience in the pharmaceutical, medical device, and medical technology sectors, where he and his teams have worked on 30+ new technology launches across areas of cataract, refractive, and vitreoretinal surgery, diagnostics, and digital health. Adam is most passionate about building and leading high impact teams focused on “white-space” new ventures and opportunities. Prior to TearLab, Adam most recently served as the Head of Dry Eye Devices at Alcon, where he was responsible for launching and leading this new business unit for the organization. Over his 13 years at Alcon, he has held leadership roles in various sales, marketing, and strategy functions across their surgical and vision care businesses. Adam earned his M.B.A from MIT’s Sloan School of Management, with a focus on Innovation Leadership, and his B.S. from Indiana University’s Kelley School of Business, where he completed a double major in Marketing and Operations.
Benjamin Sullivan, PhD
Chief Scientific Officer
Benjamin Sullivan, PhD
Chief Scientific Officer
Benjamin Sullivan is Co-Founder and Chief Scientific Officer of TearLab Corp. He graduated from Boston University in 1997 with a B.S. in Biomedical Engineering (summa cum laude). He went on to research the effects of dry eye disease on molecular profiles of the tear film while at the Schepens Eye Research Institute affiliate of Harvard Medical School, prior to obtaining his Ph.D. in Bioengineering at the University of California, San Diego. Benjamin’s research on nanotechnology, microfluidics, molecular biology and clinical trial design has been widely cited in the peer-reviewed literature. His work has led to dozens of patents and helped create companies in the fields of ophthalmology, biotechnology and early cancer detection. His current work is focused on applied electromechanical phenomena at the nanoscale with an emphasis on improving specificity of diagnostic assays. Benjamin is also a co-founder and Director Lµbris LLC.
Sam Fakhoury
Chief Operating Officer
Sam Fakhoury
Chief Operating Officer
Sam Fakhoury joined TearLab Corporation in December 2014 as the Director of Quality and Compliance. He then became the Vice President of Quality, Compliance and Supply Chain in August 2016, advancing to the position of Chief Operating Officer in September 2020. Mr. Fakhoury has over than 19 years of experience in Operations in the medical device industry, most recently with Johnson and Johnson. Mr. Fakhoury holds a Degree in Electronic Engineering from the Southern California Institute of Technology and a Degree in Business Management from the University of Phoenix.
John Lund, MBA
Chief Financial Officer
John Lund, MBA
Chief Financial Officer
John Lund joined TearLab in July 2022. John brings over 25 years of financial executive experience encompassing healthcare, private equity backed, high-growth companies including: analyzing the financial performance of business operations, leading and integrating acquisitions, and establishing the financial infrastructure needed to support operations. John also has extensive experience in mergers and acquisitions, having successfully led nearly 20 in prior roles. Recently, John was CFO at Behavioral Innovations–a private equity backed company that grew from 25 locations to over 75 during his tenure. Prior to that, John was the CFO at Behavioral Health Group, another private equity backed company that provides opioid addiction treatment in multiple states. John also served as CFO at Reliant Rehabilitation–a private equity backed company that provides physical therapy to over 700 nursing homes across 30 states. John began his career at KPMG where he served as audit manager. John is a Certified Public Accountant and earned his MBA from the Kellogg School of Management at Northwestern University. John also holds an accounting degree from the University of North Texas.
Michael Berg
Head of Regulatory, Reimbursement and Clinical
Michael Berg
Head of Regulatory, Reimbursement and Clinical
Michael Berg has over 25 years of experience introducing new technology into the professional healthcare marketplace, through his own companies, as a consultant to the industry and a founder of TearLab. He is experienced in product and business development, finance, manufacturing, marketing and strategic planning, domestic and international distribution, third-party reimbursement and regulatory affairs.
With TearLab since 2007, Michael has formulated and implemented successful strategies to obtain CLIA Waiver categorization for point-of-care technology, solicited and obtained CPT coding through the American Medical Association process, and facilitated strong reimbursement for eye care professionals through the Medicare (CMS) and private health insurer system. Focused on market development and physician education, Michael is experienced in the design and coordination of clinical studies, positioning products to meet clinical guidelines, evidence-based medicine and pay-for-performance criteria, and co-promotion with the pharmaceutical industry to link diagnosis and therapy. Michael received his BA from the University of Notre Dame.
Carey Kelson
Head of Global Marketing and International Sales
Carey Kelson
Head of Global Marketing and International Sales
Carey Kelson joined the team as Head of Global Marketing in August 2022. Carey brings over 20 years of eyecare experience encompassing sales and marketing roles of increasing responsibility for the top companies in the industry (Allergan, AMO, and Alcon). Carey is a sales, marketing, and operations strategist, that builds and scales organizations for growth and profitability, defines life cycle strategy and leads cross-functional teams to expand core products and introduce new products to market. Recently, Carey was the Global Director, Downstream Marketing at Argon Medical–a private equity backed medical device company in the Interventional Radiology space that grew 21.9% in 2021 vs PY. Prior to that, Carey held Global Marketing leadership roles in the Ocular Surface Health, Cataract, and Visualization Franchises at Alcon. Carey is currently a board member of the Tarrant County Chapter of JDRF.
Carey earned his Bachelors of Business Administration in Marketing from the McCombs School of Business at the University of Texas at Austin and his Executive MBA from Marshall School of Business at the University of Southern California.
John Steenbakkers
Head of US Sales
John Steenbakkers
Head of US Sales
John Steenbakkers joined TearLab in October 2020 to oversee relationships with key strategic partners in the ophthalmic community. John brings with him over 20 years of ophthalmic industry experience in the pharmaceutical, surgical and medical device spaces where he has sharpened his understanding and skillsets to better understand what his medical professional customers need. John is dedicated and passionate about serving his customers while leading the sales team within TearLab. His attention to his customer needs and selfless leadership style is something he works on bringing to the TearLab sales team. Prior to TearLab, John spent 22 years with Alcon, most recently serving as National Accounts Director where he oversaw and focused on building relationships and business between Alcon and their private equity owned customer base. During his 22 years at Alcon John held both sales and leadership roles within their Pharmaceutical and Cataract Surgical departments. John earned his B.A. in Finance at the University of Utah from the David Eccles School of Business.
Steve Zmina
Head of Engineering and Manufacturing
Steve Zmina
Head of Engineering and Manufacturing
Steve Zmina has more than 28 years of product development experience in a number of high technology industries including medical, telecommunications, semiconductor, and industrial and high-volume consumer products. His wide range of skills include product development, product marketing, manufacturing, and operations. Prior to TearLab Corporation, Steve was the Vice President of Product Development at Thermoscan, in San Diego, California, developing professional and consumer infrared ear thermometers. He has also been responsible for the development of a variety of high-volume consumer products for Tandy Electronics. While at Tandy, his product development team developed over 40 new, high-volume consumer products. He introduced digital signal processing into very low-cost consumer products to significantly improve product performance and value to the customer. Steve has also held a number of other executive level positions in the semiconductor and power supply industries, developing products for the consumer and industrial markets. Steve has BSEE and MSEE degrees from Purdue University in semiconductor electronics.
BOARD OF DIRECTORS
Jim Mazzo
Executive Chairman of the Board
Jim Mazzo
Executive Chairman of the Board
James V. (Jim) Mazzo is Executive Chairman of Neurotech, a retinal implant company; and Chief Executive Officer and president for Avellino Labs, a biotechnology and genetic science company. He is also an Advisor for Zeiss and an Advisor for Bain Consulting.
Mazzo is one of the ophthalmic industry’s best known and most respected business leaders with more than 40 years of proven experience. His global reputation for building and running world-class organizations is based on 22 years of leading Allergan’s North American and European eye care organizations; seven years as Chairman, President and CEO of Advanced Medical Optics (AMO); four years as EVP of Abbott’s global ophthalmology business; three years as Executive Chair and CEO of AcuFocus; and four years as Global President of Ophthalmic Devices for Carl Zeiss Meditec.
Additionally, he is the Founder and Chairman of OCTANe, a member of the International Intraocular Implant Club (lllC) and Executive Committee Board Member with the Medical Device Manufacturers Association (MDMA).
Mazzo is on the ASCRS Governing Board, the AAO Foundation Advisory Board, the AGS Foundation Advisory Board, a Chair Member of the Gavin Herbert Eye Institute, a Consultant of Anivive Lifesciences, sits on the Board of Visus Therapeutics, Refocus Group, Centricity Vision, LensGen, Iantrek, and Preceyes, serves on NASA’s Mission to Mars Committee, is an Officer in the Order of St. John, and is also a Board Member of the Anaheim Ducks Foundation.
His accomplishments and contributions to the healthcare industry and business and educational communities include serving as Board Chairman for AdvaMed; serving on the University of California at Irvine foundation; the Vice Chair Trustee, Chapman University; and years of dedicated experience with the medical device industry including cardiology, orthopedics as well as ophthalmology. Jim has also been recognized as a Top 100 Innovator in Ophthalmology multiple times and in 2021 received the Ellis Island Medal of Honor.
Barak Azmon, MD
Barak Azmon, MD
Ophthalmologist; Co-Founder and CEO of Notal Vision, Co-Founder of Vision6, Pres-by, Azura Ophthalmics, Cameraeyes, and Venture Partner at Accuitive Medical Ventures
David Carter, MBA
David Carter, MBA
David Carter is a Partner and member of CRG’s Investment Committee. CRG is a healthcare investment firm that manages over $4 billion of institutional capital. Mr. Carter joined CRG in 2003 and has more than 30 years of investment and advisory experience. In addition to focusing on sourcing, execution and monitoring existing CRG investments he is also responsible for staffing CRG deal teams. Prior to joining CRG, Mr. Carter was a Partner at Palestra Capital, a hedge fund focused on risk arbitrage and special situations. Before joining Palestra, Mr. Carter was a high yield analyst at Furman Selz LLC (ING Barings), where he was responsible for coverage of healthcare-related high yield debt. Previously, Mr. Carter was an investment banking analyst in the Healthcare Group at Chemical Bank and a research assistant in the mergers and acquisitions group of Morgan Stanley. Over the course of his career, he has closed in excess of $6 billion of financing activity. Mr. Carter received a Bachelor of Science in finance from Pennsylvania State University in 1988. He received a Master of Arts degree in information science and systems in 1994 and an M.B.A. in 1996, both from Columbia University.
Uri Geiger, PhD
Uri Geiger, PhD
Dr. Uri Geiger has served as Managing Partner of Accelmed, a private equity investment firm he co-founded in 2009 focused on medical device companies. Prior to founding Accelmed, Dr. Geiger served as the CEO of Exalenz Bioscience Ltd., a medical technology company, from May 2006 until December 2008. Prior to that, Dr. Geiger co-founded and was the CEO of GalayOr Networks, a developer of optical components from 2001 until 2003. Dr. Geiger was also the founding partner of Dragon Variation Fund in 2000, one of Israel’s first hedge funds, which was sold to Migdal in 2007.
Dr. Geiger worked on Wall Street during the 1990s, where he gained a broad understanding of and significant experience in capital markets. Dr. Geiger was formerly an adjunct professor at Tel Aviv University’s Recanati School of Business where he lectured on private equity and venture capital and authored the books “Startup Companies and Venture Capital” and “From Concept to Wall Street.”
He earned his doctorate from New York’s Columbia University Center for Law & Economics, where he majored in global equity markets. Dr. Geiger previously served on the board of directors of EndoChoice Holdings Inc. from January 2014 until March 2016.
Uri Geiger brings extensive entrepreneurial, management and investment know-how having created and built many successful medical device enterprise.
Richard L. Lindstrom, MD
Richard L. Lindstrom, MD
Dr. Lindstrom is the founder and attending surgeon at Minnesota Eye Consultants, Adjunct Clinic Professor Emeritus at the University of Minnesota Department of Ophthalmology, and visiting professor at the UC Irvine Gavin Herbert Eye Institute. He is a board-certified ophthalmologist and internationally recognized leader in corneal, cataract, refractive, glaucoma and laser surgery. He has been at the forefront of ophthalmology’s evolutionary changes throughout his career, as a recognized researcher, teacher, inventor, writer, lecturer and highly acclaimed physician and surgeon.
After graduating Magna Cum Laude from the College of Liberal Arts at the University of Minnesota, Dr. Lindstrom completed his doctorate degree in medicine in 1972. He conducted research, residency and fellowship training in cornea at the University of Minnesota and affiliated hospitals and extended his anterior segment surgery fellowship training at Mary Shiels Hospital in Dallas followed by a Heed Fellowship in Glaucoma at University Hospital in Salt Lake City, after two years of private practice in Dallas, TX. In 1980 Dr. Lindstrom returned to the University of Minnesota, where he spent ten years on the faculty of the Department of Ophthalmology, the last two as a full professor and the Harold G. Scheie Research Chair. He continues as Adjunct Clinical Professor Emeritus, Chairman of the Vision Foundation, a board director for the University of Minnesota Foundation and Associate Director of the Minnesota Lions Eye Bank. He entered private practice in 1989 and has led the growth and expansion of Minnesota Eye Consultants having served as managing partner for 15 years. He is also CO-medical director of Precision Lens and Refractec. He is Chief Medical Editor of the USA and International editions of Ocular Surgery News, which reaches 82,000 ophthalmologists worldwide.
Dr. Lindstrom served as President (2007-2008) of the American Society of Cataract and Refractive Surgery; he also served as chair for 6 years and continues on the Executive and is for the ASCRS and its Foundation. He has also served as the President of the International Society of Refractive Surgery of the American Academy of Ophthalmology, The International Intraocular Implant Club, and the International Refractive Surgery Club.
He has served for 20 years Chairman and CEO of Lindstrom Cleaning and Construction, a three-generation family business. He has endowed funds supporting the University Of Minnesota Department Of Ophthalmology, the Eye Bank Association of America, and the University of Minnesota Tennis Team.
Dr. Lindstrom has been awarded over 40 patents in ophthalmology and has developed a number of corneal preservation solutions, intraocular lenses and instruments that are used in clinical practices globally. He serves on the Board of Directors of Lindstrom Restoration, Minnesota Eye Consultants, TearLab, Ocular Therapeutix, Imprimis, Refractec, AcuFocus, Encore, ForSight#6, IICayr, Alphaeon, Aviana, PogoTec, Equinox, Precision Lens, Iantech, Visionary Ventures, and Flying L Ventures. Prior Boards of acquired companies include: Eyeonics, Advanced Vision Science, Midwest Surgical Services, Laserboyz, Citation Ventures, LVCI Vision, TLC Vision, Sightpath, Onpoint Medical Diagnostics, Vision Twenty-One, Occulogix and Wavetec. Not for profit Board service includes: The University of Minnesota Foundation, University of Minnesota Vision Foundation, InnerCityTennis, Minnesota Eye Consultants Foundation, the ASCRS Executive committee and Foundation Board, The International Society of Refractive Surgery of the American Academy of Ophthalmology.
A frequent lecturer throughout the world on cornea, cataract, glaucoma, laser, and refractive surgery, he has presented over 40 named lectures and keynote speeches before professional societies in the U.S. and abroad, most recently giving the Kelman Lecture at the American Academy of Ophthalmology, the Castroviejo Lecture at the Cornea Society. The Blumenthal Memorial lecture in Jerusalem, Israel, the Benedetto Strampelli Medal Lecture in Rome, Italy, and the Albrecht von Garefe-Vorlesung Innovator’s Lecture in NureNberg, Germany.
Dr. Lindstrom serves on a number of journal editorial boards, including JCRS and JRS. He is the Honorary Editor-in-Chief of the U.S./Chinese Journal of Ophthalmology. He has co-edited seven books, published over 350 peer reviewed journal articles and 60 book chapters. His professional affiliations are extensive.
He is the recipient of numerous awards for distinguished service by national and international ophthalmology associations, including the LANS, Barraquer and the first lifetime achievement award from the International Society of Refractive Surgery in October 1995 and also was honoured with A SECOND lifetime achievement award in October 2002, the Binkhorst and Kelman Lecture Award from the American Society of Cataract and Refractive Surgery, the Bausch and Lomb Lifetime Achievement Award, April 2005, and the Paton Award and NACT Award from the Eye Bank Association of America.
Dr. Lindstrom lives in Minneapolis on the shores of Lake Minnetonka with his wife Jaci and has two children and 5 grandchildren.
Dolev Rafaeli, PhD, MBA
Dolev Rafaeli, PhD, MBA
Dr. Rafaeli has served as Chief Executive Officer of PhotoMedex Inc (NASDAQ: PHMD) from December 2011 until May 2017. Previously, starting in 2006, he served as president and CEO of Radiancy IInc. (a private company that was merged into PhotoMedex) He has over 30 years of experience managing international operations.
Prior to joining Radiancy, Inc., Dr. Rafaeli served from 2004 to 2006 as president and CEO of the USR Group, a consumer electronics products manufacturer, managing operations in Israel, China, Hong Kong and the U.S. Between 2000 and 2004, Dr. Rafaeli founded and served as general manager of Orbotech Ltd. (ORBK-NASDAQ), an automated optical inspection capital equipment manufacturer for the electronics industry in China and Hong Kong, where he was instrumental in building these operations into a $100 million a year business. Between 1997 and 2000, Dr. Rafaeli served as CEO of USR Ltd., a global electronics contract manufacturing company providing design, supply chain and manufacturing services to dozens of clients in the communications, consumer and medical device fields. USR Ltd. employed approximately 1,000 individuals.
Dr. Rafaeli previously served as director of operations and manager of the Arad manufacturing facility for Motorola in its Land Mobile Product Solutions division, manufacturing and distributing communications, consumer and other infrastructure electronics products in excess of $400 million annually. He received honors as the 2013 Deloitte Technology Fast 500™ ranked #131 with 925% revenue growth, the 2014 Deloitte Technology Fast 500™ ranked #90 with 1301% revenue growth, the 2018 Deloitte Technology Fast 500™ ranked #38 with 3338% revenue growth, Investment Deal of the Year, award winner for the SmartCEO Magazine, finalist for the Ernst & Young 2013 Entrepreneur of the Year.
He has extensive experience in mergers and acquisitions, both domestically and internationally, and particularly involving public company acquisitions, including Photomedex Inc. (formerly, Nasdaq:PHMD), LCA Vision, Inc. (formerly, Nasdaq: LCAV). Currently he serves as the president and CEO and a member of the board of directors of Strata Skin Sciences (Nasdaq:SSKN), and has previously served on the boards of FC Global Realty (NASDAQ:FCRE) and Gadsden Properties Inc. (NASDAQ:GADS).
Dr. Rafaeli graduated with a B.Sc. in industrial engineering and management cum laude and a M.Sc. in operations management from the Technion-Israel Institute of Technology, and holds a Ph.D. in business management from Century University and an MBA (with distinction) from Cornell University.
Douglas Strang, MBA
Douglas Strang, MBA
Mr. Strang was a partner at PwC and retired after more than 35 years of employment with the firm. His most recent position was as the firm’s Global Pharmaceuticals & Life Science Advisory Leader. He started his career with the firm in the audit practice where he performed financial audits primarily in the healthcare industry. He later transitioned into the firm’s forensic and risk practice where Mr. Strang led projects including Board appointed financial investigations, fraud and abuse matters in the life sciences industry and various other healthcare compliance regulatory matters. He also has significant experience working in the area of Merger and Acquisitions where he assisted his clients with financial due diligences and merger integrations. In addition to the Global leadership role, Mr. Strang was the US Pharmaceutical and Life Sciences Advisory Leader beginning in 2009 and transitioned to the European leader in 2019. The PwC practice he led focused on providing value-added solutions across the Life Sciences value chain including M&A, R&D, manufacturing and supply chain, commercial, and finance operations. Mr. Strang currently serves on the Board of Directors of Strata Skin Sciences (Nasdaq: SSKN) and is also the Audit Committee Chair. He is a Certified Public Accountant in the State of Pennsylvania and holds a BS degree in accounting from Penn State University and an MBA from Villanova University.
MEDICAL ADVISORY BOARD
Ophthalmology Board
Lisa Nijm, MD
Chief Medical Advisor for Ophthalmology
Lisa Nijm, MD
Chief Medical Advisor for Ophthalmology
Dr. Lisa Nijm is the Chief Medical Advisor for Ophthalmology for Trukera Medical. Dr. Nijm is a board-certified ophthalmologist and corneal surgeon at Warrenville Eyecare and LASIK and an assistant clinical professor of ophthalmology at the University of Illinois Eye and Ear Infirmary in Chicago. She also serves as the CEO of Women in Ophthalmology, mentors’ physicians and advises leading medical device and pharmaceutical companies on new innovations in ophthalmology.
Mitchell Jackson, MD
Mitchell Jackson, MD
Dr. Mitchell Jackson is a member of the Trukera Medical Advisory Board. Dr. Jackson is the Founder and CEO of Jacksoneye, his private practice of 29 years located in Lake Villa, Illinois. He graduated from Pomona College, completed his medical training at FUHS/The Chicago Medical School, and completed his Ophthalmology residency at the University of Chicago Hospitals. Dr. Jackson is also a board member and VP of the American College of Eye Surgeons (ACES), founding member of the American College of Ophthalmic Surgeons (AECOS), and a founding member and past 2018 President of the Cataract External Disease and Refractive Surgery Society (CEDARS/ASPENS).
Jai G. Parekh, MD, MBA, FAAO
Jai G. Parekh, MD, MBA, FAAO
Dr. Jai Parekh is a member of the Trukera Medical Advisory Board. Dr. Parekh, MD, MBA, FAAO, is a dual-trained internist and board-certified anterior segment surgeon with extensive experience in clinical and academic practice, pharmaceutical and medical device technology, medical affairs and R&D, clinical and business development, hospital administration, healthcare IT and digital medicine, private equity and investing, philanthropy and entrepreneurship. Dr. Parekh recently served as Chief Medical Officer of Global Eye Care at Allergan from 2015 to 2020 where he provided ambassadorship, leadership and directed medical affairs, working with key stakeholders on several launches. He has held consulting and strategic roles for numerous eye care companies on business development, marketing, and strategic growth. Dr. Parekh holds an MBA from the Fuqua School of Business at Duke University, an MD from Boston University School of Medicine, and a BA from Boston University’s Combined Early Acceptance Medical School Program.
Darrell White, MD
Darrell White, MD
Dr. Darrell White is a member of the Trukera Medical Advisory Board. Dr. White is the founder of SkyVision Centers, one of the oldest Dry Eye Centers of Excellence in the U.S., located in Westlake, Ohio. He has been one of the preeminent ophthalmic surgeons in the area since 1991. He has held numerous leadership positions including President of the Cleveland Ophthalmological Society, and Medical Director of the first excimer laser center in Northeast Ohio. Dr. White continues to be a leader among ophthalmic surgeons in the area, bringing new technologies, advanced concepts and new products to Northeast Ohio.
Frank Bucci, MD, MBA
Frank Bucci, MD, MBA
Dr. Frank Bucci is a member of the Trukera Medical Advisory Board. Dr. Bucci began his education by attending Rollins College and graduated with a BA in economics in 1974. In 1978, Dr. Bucci received his MBA with a concentration in health care management from Cornell University. Dr. Bucci is the founder and medical director of Bucci Laser Vision Institute in Wilkes-Barre, PA. After completing his ophthalmology residency at Albany Medical Center in Albany, New York, he completed a cornea, refractive, and anterior segment fellowship with Drs. Lindstrom and Holland at the University of Minnesota. Dr. Bucci has published over 35 peer-reviewed articles and has given over 250 abstract supported presentations at major ophthalmic meetings worldwide. He has implanted over 12,000 multifocal IOLs and has published extensively in the areas of antibiotics, NSAIDs, dry eye medications, and presbyopia correcting IOLs. Dr. Bucci has been an industry wide consultant, thought leader, and advisory board member for multiple ophthalmic corporations including AcuFocus, Allergan, Bausch & Lomb, Glaukos, Johnson and Johnson, LENSAR, Ocular Therapeutix, Novartis, Physician Recommended Nutriceuticals, Omeros, Santen, Refocus Group, Tear Lab, and others.
Marguerite B. McDonald, MD, FACS
Marguerite B. McDonald, MD, FACS
Dr. McDonald graduated from Columbia College of Physicians and Surgeons and did her ophthalmology residency at Manhattan Eye and Ear/Cornell. This was followed by a cornea fellowship with Dr Herbert Kaufman at LSU.
Currently, she is a Clinical Professor of Ophthalmology at New York University in Manhattan and a Clinical Professor of Ophthalmology at Tulane University Medical School in New Orleans, as well as a cornea/refractive/cataract surgeon with OCLI Vision on Long Island, New York.
For her pioneering work in refractive surgery that also included development and performance of the first excimer laser procedure in patients, she has received over 90 professional recognition awards including the ISRK Lans Distinguished Refractive Surgeon Lecture, the ISRK/AAO Barraquer Lecture, the AAO Whitney Sampson Lecture, the AAO Binkhorst Lecture, and the ASCRS Steinert Lecture. She serves on numerous Editorial Boards of clinical and scientific journals and is an active member of multiple national and international professional societies that have accorded recognition including: Honorary President, Founding Member, International Association of Women Eye Surgeons; President, Association of Women Eye Surgeons; President, ASCRS; President, ISRS/AAO; and President, International Society for Contact Lens Research. She has over 1,800 publications and a number of patents in the fields of cornea and refractive surgery.
Dr. McDonald is also the director of the OCLI Vision Dry Eye Center of Excellence.
Optometry Board
Damon Dierker, OD, FAAO
Chief Medical Advisory for Optometry
Damon Dierker, OD, FAAO
Chief Medical Advisory for Optometry
Dr. Damon Dierker is the Chief Medical Advisor for Optometry for Trukera Medical. Dr. Dierker is Director of Optometric Services at Eye Surgeons of Indiana and an adjunct faculty member at the Indiana University School of Optometry. He practices consultative optometry with special interests in ocular surface disease and retinal disorders. He has developed a dedicated dry eye clinic within his practice and helps colleagues across the country in this area as the creator of Dry Eye Boot Camp and co-founder of Eyes on Dry Eye. Additionally, he serves as Immediate Past President of the Indiana Optometric Association.
David Kading, OD, FAAO, FCLSA
David Kading, OD, FAAO, FCLSA
Dr. David Kading is a member of the Trukera Medical Advisory Board. Dr. Kading has been recognized as one of the top 50 optometry influencers of all time, as one of the top 250 innovators, and listed as one of the top 10 best practices in eyecare. He has three practices in the Seattle focuses on Dry Eye, Specialty Lenses and Myopia Management. He Co-Owns Optometric Insights which is changing the way students and doctors perceive practice. He performs research as part of the post-graduate Residency program that he hosts in Seattle. He lectures internationally and has written thousands of papers and articles. Dr. Kading’s teaching style brings about innovation and simplified perspectives to longstanding conditions.
Douglas K. Devries, O.D.
Douglas K. Devries, O.D.
Dr. Douglas Devries is a member of the Trukera Medical Advisory Board. Dr. Devries co-founded and developed Eye Care Associates of Nevada, which is a state-wide co-management network of referring optometrists and primary care physicians. He is also the clinic Director and Managing Partner for the practice; a medical/surgical ophthalmology practice located in Reno and providing services in Reno and Elko, Nevada. Additionally, he is responsible for the optometric residency program starting in 1992. He is also a managing partner for Ophthalmic Resources LCC, a national diagnostic, sales and Distribution Company serving the eye care profession in the diagnosis and treatment of ocular surface disease. He received his bachelors of Science Business from the University of Nevada, and got his Doctor of Optometry at Pacific University in Oregon.
Selina McGee, OD, FAAO
Selina McGee, OD, FAAO
Dr. Selina McGee is a member of the Trukera Medical Advisory Board. Dr. McGee is the founder and owner of BeSpoke Vision, a private practice that offers patients a wide range of optometric care via its dry eye center, specialty contact lens clinic and aesthetics suite. She is a renowned national and international speaker. She is an Adjunct Assistant Professor at the Northeastern State University College of Optometry. She is on faculty at The Oklahoma Medical Research Foundation. She currently serves as President for the Intrepid Eye Society, Trustee on the SECO Board, and the Board of Examiners in Oklahoma. She is a Fellow of the American Academy of Optometry and a Diplomate of the American Board of Optometry, and is Past-President of the Oklahoma Association of Optometric Physicians. Dr. McGee is the current co-medical editor of Modern Optometry and has dozens of publications to her credit in Optometry Times, Review of Optometry, and Optometric Management. She earned her Bachelor of Science in Biology (where she graduated Summa Cum Laude) and Doctor of Optometry (also Summa Cum Laude) from Northeastern State University College of Optometry.
NEWS & UPDATES
Sept 5, 2023: Trukera Medical Announces Manufacturing Discontinuation of TearLab Osmolarity System
Mar 20, 2023: Adam Szaronos, Chief Executive Officer, Presents the Vision for Trukera and Innovations Dedicated to Advancing Corneal Health at the Emerging Medtech Summit
Mar 1, 2023: Ben Sullivan, Chief Scientific Officer, Presents Trukera and ScoutPro at the OIS Session During the SECO Meeting in Atlanta, GA
Jan 16, 2023: Adam Szaronos, Chief Executive Officer, Presents the Vision for Trukera and Discusses the Launch of ScoutPro During the Disruptive Innovation Session at Royal Hawaiian Eye 2023
Jan 15, 2023: Jim Mazzo, Trukera’s Executive Chairman of the Board, Receives the Dick Lindstrom Leadership Award at Royal Hawaiian Eye 2023
Older Entries
Oct 13, 2022: Trukera Medical Hosted Experts Lisa Nijm, MD, Mitch Jackson, MD, and Damon Dierker, DO to Discuss the Launch of ScoutPro
Oct 7, 2022: Trukera Medical CEO Adam Szaronos Presents New Company Vision and ScoutPro Launch at Eyecelerator (READ MORE)
Sep 19, 2022: EyeWireTV – Trukera™ Medical Launches New ScoutPro™ Osmolarity System (READ MORE)
Sep 7, 2022: TearLab® Announces Corporate Name Change to Trukera™ Medical, Positions Company for Further Expansion in Cornea Health (READ MORE)
Apr 22, 2022: Ocular Surface Disease Treatment Becoming Essential in Refractive Cataract Surgery (READ MORE)
Dec 9, 2021: TearLab Corporation Announces Adam Szaronos as President and Chief Executive Officer, and Jim Mazzo as Executive Chairman of the Board (READ MORE)
Jul 9, 2020: TearLab Closes Acquisition by Accelmed Partners (READ MORE)
Click here for older entries
Contact us today to learn more
Phone
1-855-832-7522
Fax
858-812-0540
Mailing
Trukera Medical: Corporate Headquarters
940 South Kimball Avenue
Southlake, TX 76092
Trukera Medical: Operations and Technical Services
150 La Terraza Boulevard, Suite 101
Escondido, CA 92025